KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Sales (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Return on Sales for 11 consecutive years, with 95.27% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 9534.0% to 95.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, up 15.0% year-over-year, with the annual reading at 0.0% for FY2025, 15.0% up from the prior year.
  • Return on Sales hit 95.27% in Q4 2025 for Fulgent Genetics, up from 0.08% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 95.27% in Q4 2025 to a low of 1.74% in Q4 2023.
  • Historically, Return on Sales has averaged 4.74% across 5 years, with a median of 0.07% in 2024.
  • Biggest five-year swings in Return on Sales: tumbled -200bps in 2023 and later soared 9534bps in 2025.
  • Year by year, Return on Sales stood at 0.41% in 2021, then crashed by -37bps to 0.26% in 2022, then tumbled by -777bps to 1.74% in 2023, then soared by 96bps to 0.06% in 2024, then surged by 151310bps to 95.27% in 2025.
  • Business Quant data shows Return on Sales for FLGT at 95.27% in Q4 2025, 0.08% in Q3 2025, and 0.23% in Q2 2025.